PANTHERx and the Hurricane Harvey Disaster
The effects of Hurricane Harvey have impacted thousands of lives in horrendous ways. Those removed from the Gulf Coast cannot imagine the reality these innocent people are enduring. They are …
The effects of Hurricane Harvey have impacted thousands of lives in horrendous ways. Those removed from the Gulf Coast cannot imagine the reality these innocent people are enduring. They are …
PANTHERx Specialty Pharmacy has earned the #1 ranking in the Zitter Health Insights Patient Satisfaction Survey for the second quarter of 2017. This achievement follows on the heels of PANTHERx® …
PANTHERx® Specialty Pharmacy has again been recognized in the top 100 of the Inc. 500 list of the fastest growing companies in the United States. The 2017 Inc 500 list, …
Press Release originally published on PRNewswire PITTSBURGH, PA – The Center for Pharmacy Practice Accreditation (CPPA), a partnership of pharmacy-based organizations, announced today that it has awarded specialty pharmacy practice …
PANTHERx® is proud to sponsor the 2017 PBGH Rx Solutions Forum on May 23rd at the Pittsburgh Marriott City Center.
Re-posted from PR Newswire PANTHERx® Specialty Pharmacy has been recognized as the winner of the Specialty Pharmacy Patient Choice Awards™ for the non-PBM/payer category presented during the 2017 Asembia Specialty …
This past Wednesday, our Chairman & CEO, Dr. Gordon J. Vanscoy, was recognized by the Pittsburgh Business times at the 2nd Annual Outstanding CEOs & Top Executives Awards Ceremony. For …
On April 5, 2017, CSI Specialty Group released episode 51 of “The Specialty Pharmacy Podcast.” This episode featured Dr. Gordon J. Vanscoy, PANTHERx® Specialty Pharmacy Chairman and CEO. Among the …
PANTHERx will dispense KISQALI® (ribociclib) as a first-line treatment for postmenopausal women with an advanced form of breast cancer. The Food and Drug Administration has approved KISQALI® as a once-daily …
We are proud to announce that Specialty Pharmacy Times and Zitter Health Insights have selected PANTHERx® as a finalist in the Non-PBM/Payer Specialty Pharmacy category. PANTHERx® Specialty Pharmacy’s inclusion as …